Abstract

This study explores the prognostic implications of diagnostic delays and initial symptoms in pancreatic cancer patients. By analyzing clinical data and patient records, the research assesses how delays in diagnosis and the nature of presenting symptoms influence patient outcomes, including survival rates and response to treatment. The findings indicate that prolonged diagnostic delays are associated with worse prognoses, while specific initial symptoms may correlate with more advanced disease at diagnosis. This study underscores the critical need for timely diagnosis and accurate symptom assessment to improve patient management and outcomes in pancreatic cancer care. Recommendations for enhancing early detection and addressing symptom-related challenges are provided.